Abdelmalek, M., Suzuki, A., Guy, C., Smith, A., Adeyefa, B., Pan, Y., … Diehl, A. M. (2010). Statin Therapy Decreases Risk of Hepatic Steatosis and Lobular Inflammation in Patients with Nonalcoholic Fatty Liver Disease. In American Journal of Gastroenterology (Vol. 105, pp. S116–S116). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.14309/00000434-201010001-00313

Abdelmalek, Manal, Ayako Suzuki, Cynthia Guy, Alastair Smith, Babatunde Adeyefa, YiPing Pan, Melissa Smith, and Anna Mae Diehl. “Statin Therapy Decreases Risk of Hepatic Steatosis and Lobular Inflammation in Patients with Nonalcoholic Fatty Liver Disease.” In American Journal of Gastroenterology, 105:S116–S116. Ovid Technologies (Wolters Kluwer Health), 2010. https://doi.org/10.14309/00000434-201010001-00313.

Abdelmalek M, Suzuki A, Guy C, Smith A, Adeyefa B, Pan Y, et al. Statin Therapy Decreases Risk of Hepatic Steatosis and Lobular Inflammation in Patients with Nonalcoholic Fatty Liver Disease. In: American Journal of Gastroenterology. Ovid Technologies (Wolters Kluwer Health); 2010. p. S116–S116.

Abdelmalek, Manal, et al. “Statin Therapy Decreases Risk of Hepatic Steatosis and Lobular Inflammation in Patients with Nonalcoholic Fatty Liver Disease.” American Journal of Gastroenterology, vol. 105, Ovid Technologies (Wolters Kluwer Health), 2010, pp. S116–S116. Crossref, doi:10.14309/00000434-201010001-00313.

Abdelmalek M, Suzuki A, Guy C, Smith A, Adeyefa B, Pan Y, Smith M, Diehl AM. Statin Therapy Decreases Risk of Hepatic Steatosis and Lobular Inflammation in Patients with Nonalcoholic Fatty Liver Disease. American Journal of Gastroenterology. Ovid Technologies (Wolters Kluwer Health); 2010. p. S116–S116.